Neoadjuvant tislelizumab plus chemotherapy among patients with locally advanced cervical cancer: A prospective, single-arm, phase II trial

被引：0
|
作者：
Sheng, Jindong [1 ]
Liu, Wenxin [1 ]
Liu, Ruoyan [1 ]
Liu, Chunyan [1 ]
Wang, Bochang [1 ]
Liu, Xiangyu [1 ]
Xu, Changxiao [1 ]
Fu, Xin [1 ]
Wang, Ke [1 ]
机构：
[1] Tianjin Med Univ, Tianjin, Peoples R China
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant camrelizumab plus chemotherapy in patients with locally advanced cervical cancer (NACI): A prospective, single-arm, phase II trial
    Chen, J.
    Li, K.
    Han, Y.
    Shen, Y.
    Wang, Y.
    Song, K.
    Chen, X.
    Xia, B.
    Zou, D.
    Wang, Y.
    Ma, D.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S804 - S804
  • [2] Neoadjuvant tislelizumab plus chemotherapy among patients with advanced ovarian cancer: A prospective, single-arm, phase II study
    Zhou, Jinhua
    Liu, Wei
    Huang, Yazhen
    Ding, Hongmei
    Chen, Youguo
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S298 - S299
  • [3] Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI study): A prospective, single-arm, phase II trial
    Chen, Jing
    Li, Kezhen
    Hu, Yingjie
    Han, Yingyan
    Shen, Yuanming
    Wang, Yanzhou
    Song, Kun
    Xia, Bairong
    Chen, Xiaojun
    Zou, Dongling
    Wang, Yingmei
    Sun, Chaoyang
    Chen, Gang
    Ma, Ding
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial
    Chen, Jing
    Han, Yingyan
    Hu, Yingjie
    Feng, Xue
    Meng, Xiaolin
    Guo, Shuaiqingying
    Sun, Chaoyang
    Chen, Gang
    Li, Kezhen
    BMJ OPEN, 2023, 13 (05):
  • [5] Scientific Plenary Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): A prospective, single-arm, phase II trial
    Hu, Yingjie
    Chen, Jing
    Shen, Yuanming
    Wang, Yanzhou
    Song, Kun
    Xia, Bairong
    Chen, Xiaojun
    Zou, Dongling
    Wang, Yingmei
    Chen, Gang
    Sun, Chaoyang
    Ma, Ding
    Li, Kezhen
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S13 - S14
  • [6] CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial
    Liu, Fangqi
    Yang, Li
    Wu, Yuchen
    Li, Cong
    Zhao, Jiang
    Keranmu, Adili
    Zheng, Hongtu
    Huang, Dan
    Wang, Lei
    Tong, Tong
    Xu, Junyan
    Zhu, Ji
    Cai, Sanjun
    Xu, Ye
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (06) : 589 - 597
  • [7] Neoadjuvant Chemotherapy plus Tislelizumab Followed by Adjuvant Tislelizumab for Locoregionally Advanced Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
    Shiran, S.
    Huang, X.
    Wang, K.
    Wu, R.
    Wang, J.
    Zhang, Y.
    Qu, Y.
    Chen, X.
    Zhang, J.
    Luo, J.
    Yi, J.
    Zhou, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E791 - E791
  • [8] CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase Ⅱ trial
    Fangqi Liu
    Li Yang
    Yuchen Wu
    Cong Li
    Jiang Zhao
    Adili Keranmu
    Hongtu Zheng
    Dan Huang
    Lei Wang
    Tong Tong
    Junyan Xu
    Ji Zhu
    Sanjun Cai
    Ye Xu
    ChineseJournalofCancerResearch, 2016, 28 (06) : 589 - 597
  • [9] Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
    Li, Kezhen
    Chen, Jing
    Hu, Yingjie
    Wang, Yan-Zhou
    Shen, Yuanming
    Chen, Gang
    Peng, Wenju
    Fang, Zixuan
    Xia, Bairong
    Chen, Xiaojun
    Song, Kun
    Wang, Yingmei
    Zou, Dongling
    Wang, Yan-Chun
    Han, Yingyan
    Feng, Xue
    Yuan, Jing
    Guo, Shuaiqingying
    Meng, Xiaolin
    Feng, Chenzhao
    Chen, Yin
    Yang, Jie
    Fan, Junpeng
    Wang, Jianliu
    Ai, Jihui
    Ma, Ding
    Sun, Chaoyang
    LANCET ONCOLOGY, 2024, 25 (01): : 76 - 85
  • [10] Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: A single-arm, phase II trial
    Wu, Wenjie
    Yao, Jie
    Zhang, Tong
    Zhang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345